The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Endocrinology Drugs Market Research Report 2025
Synopsis
Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
The global Endocrinology Drugs market was valued at US$ 96820 million in 2023 and is anticipated to reach US$ 139410 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Endocrinology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrinology Drugs.
Report Scope
The Endocrinology Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocrinology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrinology Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Segment by Type
Diabetes Drugs
Testosterone Replacement Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Segment by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endocrinology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endocrinology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
The global Endocrinology Drugs market was valued at US$ 96820 million in 2023 and is anticipated to reach US$ 139410 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Endocrinology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrinology Drugs.
Report Scope
The Endocrinology Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocrinology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrinology Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Segment by Type
Diabetes Drugs
Testosterone Replacement Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Segment by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endocrinology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endocrinology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Endocrinology Drugs Market Overview
1.1 Product Overview and Scope of Endocrinology Drugs
1.2 Endocrinology Drugs Segment by Type
1.2.1 Global Endocrinology Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Diabetes Drugs
1.2.3 Testosterone Replacement Drugs
1.2.4 Human Growth Hormone Drugs
1.2.5 Thyroid Hormone Disorder Drugs
1.3 Endocrinology Drugs Segment by Application
1.3.1 Global Endocrinology Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Global Endocrinology Drugs Market Size Estimates and Forecasts
1.4.1 Global Endocrinology Drugs Revenue 2019-2030
1.4.2 Global Endocrinology Drugs Sales 2019-2030
1.4.3 Global Endocrinology Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Endocrinology Drugs Market Competition by Manufacturers
2.1 Global Endocrinology Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Endocrinology Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Endocrinology Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Endocrinology Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Endocrinology Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endocrinology Drugs, Product Type & Application
2.7 Endocrinology Drugs Market Competitive Situation and Trends
2.7.1 Endocrinology Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Endocrinology Drugs Players Market Share by Revenue
2.7.3 Global Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endocrinology Drugs Retrospective Market Scenario by Region
3.1 Global Endocrinology Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Endocrinology Drugs Global Endocrinology Drugs Sales by Region: 2019-2030
3.2.1 Global Endocrinology Drugs Sales by Region: 2019-2024
3.2.2 Global Endocrinology Drugs Sales by Region: 2025-2030
3.3 Global Endocrinology Drugs Global Endocrinology Drugs Revenue by Region: 2019-2030
3.3.1 Global Endocrinology Drugs Revenue by Region: 2019-2024
3.3.2 Global Endocrinology Drugs Revenue by Region: 2025-2030
3.4 North America Endocrinology Drugs Market Facts & Figures by Country
3.4.1 North America Endocrinology Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Endocrinology Drugs Sales by Country (2019-2030)
3.4.3 North America Endocrinology Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Endocrinology Drugs Market Facts & Figures by Country
3.5.1 Europe Endocrinology Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Endocrinology Drugs Sales by Country (2019-2030)
3.5.3 Europe Endocrinology Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endocrinology Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Endocrinology Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Endocrinology Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Endocrinology Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Endocrinology Drugs Market Facts & Figures by Country
3.7.1 Latin America Endocrinology Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Endocrinology Drugs Sales by Country (2019-2030)
3.7.3 Latin America Endocrinology Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endocrinology Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Endocrinology Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Endocrinology Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Endocrinology Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Endocrinology Drugs Sales by Type (2019-2030)
4.1.1 Global Endocrinology Drugs Sales by Type (2019-2024)
4.1.2 Global Endocrinology Drugs Sales by Type (2025-2030)
4.1.3 Global Endocrinology Drugs Sales Market Share by Type (2019-2030)
4.2 Global Endocrinology Drugs Revenue by Type (2019-2030)
4.2.1 Global Endocrinology Drugs Revenue by Type (2019-2024)
4.2.2 Global Endocrinology Drugs Revenue by Type (2025-2030)
4.2.3 Global Endocrinology Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Endocrinology Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Endocrinology Drugs Sales by Application (2019-2030)
5.1.1 Global Endocrinology Drugs Sales by Application (2019-2024)
5.1.2 Global Endocrinology Drugs Sales by Application (2025-2030)
5.1.3 Global Endocrinology Drugs Sales Market Share by Application (2019-2030)
5.2 Global Endocrinology Drugs Revenue by Application (2019-2030)
5.2.1 Global Endocrinology Drugs Revenue by Application (2019-2024)
5.2.2 Global Endocrinology Drugs Revenue by Application (2025-2030)
5.2.3 Global Endocrinology Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Endocrinology Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Endocrinology Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Endocrinology Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Endocrinology Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Endocrinology Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Endocrinology Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Endocrinology Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Endocrinology Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Endocrinology Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Endocrinology Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novo Nordisk Endocrinology Drugs Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Endocrinology Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Endocrinology Drugs Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endocrinology Drugs Industry Chain Analysis
7.2 Endocrinology Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endocrinology Drugs Production Mode & Process
7.4 Endocrinology Drugs Sales and Marketing
7.4.1 Endocrinology Drugs Sales Channels
7.4.2 Endocrinology Drugs Distributors
7.5 Endocrinology Drugs Customers
8 Endocrinology Drugs Market Dynamics
8.1 Endocrinology Drugs Industry Trends
8.2 Endocrinology Drugs Market Drivers
8.3 Endocrinology Drugs Market Challenges
8.4 Endocrinology Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Endocrinology Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Endocrinology Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Endocrinology Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Endocrinology Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Endocrinology Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Endocrinology Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Endocrinology Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Endocrinology Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Endocrinology Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Endocrinology Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Endocrinology Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Endocrinology Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endocrinology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrinology Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Endocrinology Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Endocrinology Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Endocrinology Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Endocrinology Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Endocrinology Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Endocrinology Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Endocrinology Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Endocrinology Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Endocrinology Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Endocrinology Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Endocrinology Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Endocrinology Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Endocrinology Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Endocrinology Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Endocrinology Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Endocrinology Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Endocrinology Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Endocrinology Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Endocrinology Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Endocrinology Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Endocrinology Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Endocrinology Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Endocrinology Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Endocrinology Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Endocrinology Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Endocrinology Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Endocrinology Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Endocrinology Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Endocrinology Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Endocrinology Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Endocrinology Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Endocrinology Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Endocrinology Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Endocrinology Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Endocrinology Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Endocrinology Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Endocrinology Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Endocrinology Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Endocrinology Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Endocrinology Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Endocrinology Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Endocrinology Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Endocrinology Drugs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Endocrinology Drugs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Endocrinology Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Endocrinology Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Endocrinology Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Endocrinology Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Endocrinology Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Endocrinology Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Endocrinology Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Endocrinology Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Endocrinology Drugs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Endocrinology Drugs Price (USD/Unit) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Endocrinology Drugs Product
Table 74. AbbVie Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca Endocrinology Drugs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly Endocrinology Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Merck Endocrinology Drugs Product
Table 89. Merck Recent Developments/Updates
Table 90. Novo Nordisk Corporation Information
Table 91. Novo Nordisk Description and Business Overview
Table 92. Novo Nordisk Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Novo Nordisk Endocrinology Drugs Product
Table 94. Novo Nordisk Recent Developments/Updates
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Endocrinology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sanofi Endocrinology Drugs Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Endocrinology Drugs Distributors List
Table 103. Endocrinology Drugs Customers List
Table 104. Endocrinology Drugs Market Trends
Table 105. Endocrinology Drugs Market Drivers
Table 106. Endocrinology Drugs Market Challenges
Table 107. Endocrinology Drugs Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Endocrinology Drugs
Figure 2. Global Endocrinology Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Endocrinology Drugs Market Share by Type in 2023 & 2030
Figure 4. Diabetes Drugs Product Picture
Figure 5. Testosterone Replacement Drugs Product Picture
Figure 6. Human Growth Hormone Drugs Product Picture
Figure 7. Thyroid Hormone Disorder Drugs Product Picture
Figure 8. Global Endocrinology Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Endocrinology Drugs Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Commercial Laboratories
Figure 12. Ambulatory Care Centres
Figure 13. Other Setting
Figure 14. Global Endocrinology Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Endocrinology Drugs Market Size (2019-2030) & (US$ Million)
Figure 16. Global Endocrinology Drugs Sales (2019-2030) & (K Units)
Figure 17. Global Endocrinology Drugs Average Price (USD/Unit) & (2019-2030)
Figure 18. Endocrinology Drugs Report Years Considered
Figure 19. Endocrinology Drugs Sales Share by Manufacturers in 2023
Figure 20. Global Endocrinology Drugs Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Endocrinology Drugs Players: Market Share by Revenue in 2023
Figure 22. Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Endocrinology Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Endocrinology Drugs Sales Market Share by Country (2019-2030)
Figure 25. North America Endocrinology Drugs Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Endocrinology Drugs Sales Market Share by Country (2019-2030)
Figure 29. Europe Endocrinology Drugs Revenue Market Share by Country (2019-2030)
Figure 30. Germany Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Endocrinology Drugs Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Endocrinology Drugs Revenue Market Share by Region (2019-2030)
Figure 37. China Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Endocrinology Drugs Sales Market Share by Country (2019-2030)
Figure 48. Latin America Endocrinology Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Endocrinology Drugs Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Endocrinology Drugs Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Endocrinology Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Endocrinology Drugs by Type (2019-2030)
Figure 58. Global Revenue Market Share of Endocrinology Drugs by Type (2019-2030)
Figure 59. Global Endocrinology Drugs Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Endocrinology Drugs by Application (2019-2030)
Figure 61. Global Revenue Market Share of Endocrinology Drugs by Application (2019-2030)
Figure 62. Global Endocrinology Drugs Price (USD/Unit) by Application (2019-2030)
Figure 63. Endocrinology Drugs Value Chain
Figure 64. Endocrinology Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
